Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota

Journal of Microbiology

Volumn 54, Issue 3, 2016, Pages 149-169

  Höfs, Sarah ^a   Mogavero, Selene ^a   Hube, Bernhard ^a,b,c  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

adhesion; biofilm; fungal infection; fungal bacterial interactions; host response; morphogenesis

Indexed keywords

VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; ANIMAL; CANDIDA ALBICANS; CANDIDIASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; VIRULENCE FACTORS;

EID: 84959227739     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-016-5514-0     Document Type: Review

References (282)

1. Abiko, Y., Jinbu, Y. Noguchi, T., Nishimura, M., Kusano, K., Amaratunga, P., Shibata, T., and Kaku, T. 2002. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study. Pathol. Res. Pr.198, 537–542.
2. Adam, B., Baillie, G.S., and Douglas, L.J. 2002. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol.41, 344–349.
3. Akira, S., Uematsu, S., and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell124, 783–801.
4. Akpan, A. and Morgan, R. 2002. Oral candidiasis. Postgr. Med. J.78, 455–459.
5. Al-Fattani, M.A. and Douglas, L.J. 2006. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol.55, 999–1008.
6. Antonio, M.A.D., Hawes, S.E., and Hillier, S.L. 1999. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis.180, 1950–1956.
7. Baena-Monroy, T., Moreno-Maldonado, V., Franco-Martínez, F., Aldape-Barrios, B., Qindós, G., and Sánchez-Vargas, L. 2005. Candida albicans, Staphylococcus aureus and Streptococcus mutans colonization in patients wearing dental prosthesis. Med. Oral Patol. Oral Cir. Bucal.10, 27–39.
8. Bagg, J. and Silverwood, R.W. 1986. Coagglutination reactions between Candida albicans and oral bacteria. J. Med. Microbiol.22, 165–169.
9. Baillie, G.S. and Douglas, L.J. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother.42, 1900–1905.
10. Bamford, C.V., d’Mello, A., Nobbs, A.H., Dutton, L.C., Vickerman, M.M., and Jenkinson, H.F. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun.77, 3696–3704.
11. Bates, S., de la Rosa, J.M., MacCallum, D.M., Brown, A.J.P., Gow, N.A.R., and Odds, F.C. 2007. Candida albicans Iff11, a secreted protein required for cell wall structure and virulence. Infect. Immun.75, 2922–2928.
12. Bauernfeind, A., Hörl, G., Jungwirth, R., Petermüller, C., Przyklenk, B., Weisslein-Pfister, C., Bertele, R.M., and Harms, K. 1987. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection15, 270–277.
13. Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S.S., Vecchi, A., Mantovani, A., Levitz, S.M., and Romani, L. 2004. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol.172, 3059–3069.
14. Ben-Yaacov, R., Knoller, S., Caldwell, G.A., Becker, J.M., and Koltin, Y. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother.38, 648–652.
15. Berman, J. and Sudbery, P.E. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet.3, 918–930.
16. Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B.P.A., and Thevissen, K. 2011. Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrob. Agents Chemother.55, 4033–4037.
17. Biswas, S., Van Dijck, P., and Datta, A. 2007. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev.71, 348–376.
18. Blankenship, J.R. and Mitchell, A.P. 2006. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol.9, 588–594.
19. Bokor-Bratic, M., Cankovic, M., and Dragnic, N. 2013. Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus. Eur. J. Oral Sci.121, 427–433.
20. Brodsky, I.E. and Monack, D. 2009. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin. Immunol.21, 199–207.
21. Brown, G.D. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol.6, 33–43.
22. Buffo, J., Herman, M.A., and Soll, D.R. 1984. A characterization of pH regulated dimorphism in Candida albicans. Mycopathologia30, 21–30.
23. Calabrese, D., Bille, J., and Sanglard, D. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans FLU1 conferring resistance to fluconazole. Microbiol.146, 2743–2754.
24. Calderone, R.A. and Clancy, C.J. 2012. Candida and Candidiasis, Second Edition. ASM Press. Washington, DC,USA.
25. Cambi, A., Gijzen, K., de Vries, I.J.M., Torensma, R., Joosten, B., Adema, G.J., Netea, M.G., Kullberg, B.J., Romani, L., and Figdor, C.G. 2003. The C-type lectin DC-SIGN (CD209) is an antigenuptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol.33, 532–538.
26. Cambi, A., Netea, M.G., Mora-Montes, H.M., Gow, N.A.R., Hato, S.V, Lowman, D.W., Kullberg, B.J., Torensma, R., Williams, D.L., and Figdor, C.G. 2008. Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J. Biol. Chem.283, 20590–20599.
27. Carlson, E. 1983. Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice. Infect. Immun.39, 193–197.
28. Carlson, E. and Johnson, G. 1985. Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice. Infect. Immun.50, 655–659.
29. Cassat, J.E., Lee, C.Y., and Smeltzer, M.S. 2007. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol. Biol.391, 127–144.
30. Cassone, A. 2015. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG122, 785–794.
31. Chaffin, W.L. 2008. Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev.72, 495–544.
32. Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., and Ghannoum, M.A. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol.183, 5385–5394.
33. Chang, H.T., Tsai, P.W., Huang, H.H., Liu, Y.S., Chien, T.S., and Lan, C.Y. 2012. LL37 and hBD-3 elevate the β-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic. Biochem. J.441, 963–970.
34. Chen, C.P., Posy, S., Ben-Shaul, A., Shapiro, L., and Honig, B.H. 2005. Specificity of cell-cell adhesion by classical cadherins: Critical role for low-affinity dimerization through β-strand swapping. Proc. Natl. Acad. Sci. USA.102, 8531–8536.
35. Cheng, S.C., Joosten, L.A., Kullberg, B.J., and Netea, M.G. 2012. Interplay between Candida albicans and the mammalian innate host defense. Infect. Immun.80, 1304–1313.
36. Cheng, S.C., van de Veerdonk, F.L., Lenardon, M., Stoffels, M., Plantinga, T., Smeekens, S., Rizzetto, L., Mukaremera, L., Preechasuth, K., Cavalieri, D., et al. 2011. The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J. Leukoc. Biol.90, 357–366.
37. Cheng, S.C., van de Veerdonk, F., Smeekens, S., Joosten, L.A.B., van der Meer, J.W.M., Kullberg, B.J., and Netea, M.G. 2010. Candida albicans dampens host defense by downregulating IL-17 production. J. Immunol.185, 2450–2457.
38. Clemons, K. and Stevens, D. 2001. Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy. Semin. Respir. Infect.16, 60–66.
39. Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., and de Repentigny, L. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun.64, 4514–4519.
40. Conti, H.R. and Gaffen, S.L. 2010. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect.12, 518–527.
41. Costerton, J.W., Lewandowski, Z., Caldwell, D.E., Korber, D.R., and Lappin-Scott, H.M. 1995. Microbial biofilms. Annu. Rev. Microbiol.49, 711–745.
42. Cua, D.J. and Tato, C.M. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol10, 479–489.
43. Cugini, C., Calfee, M.W., Farrow, J.M., Morales, D.K., Pesci, E.C., and Hogan, D.A. 2007. Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol. Microbiol.65, 896–906.
44. Dalle, F., Wächtler, B., L’Ollivier, C., Holland, G., Bannert, N., Wilson, D., Labruère, C., Bonnin, A., and Hube, B. 2010. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell. Microbiol.12, 248–271.
45. Davis-Hanna, A., Piispanen, A., Stateva, L., and Hogan, D. 2008. Farnesol and dodecanol effects on the Candida albicans Ras1- cAMP signalling pathway and the regulation of morphogenesis. Mol. Microbiol.67, 47–62.
46. De Luca, A., Zelante, T., D’Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R.G., Bonifazi, P., Renauld, J.C., Bistoni, F., et al. 2010. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol.3, 361–373.
47. de Macedo, J.L.S. and Santos, J.B. 2005. Bacterial and fungal colonization of burn wounds. Memórias do Inst. Oswaldo Cruz100, 535–539.
48. Dennerstein, G.J. and Ellis, D.H. 2001. Oestrogen, glycogen and vaginal candidiasis. Aust N Z J Obstet. Gynaecol.41, 326–328.
49. Doherty, G.J. and McMahon, H.T. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem.78, 857–902.
50. Edgerton, M., Koshlukova, S.E., Lo, T.E., Chrzan, B.G., Straubinger, R.M., and Raj, P.A. 1998. Candidacidal activity of salivary histatins. J. Biol. Chem.273, 20438–20447.
51. Fanning, S. and Mitchell, A.P. 2012. Fungal biofilms. PLoS Pathog.8, e1002585.
52. Fehrmann, C., Jurk, K., Bertling, A., Seidel, G., Fegeler, W., Kehrel, B.E., Peters, G., Becker, K., and Heilmann, C. 2013. Role for the fibrinogen-binding proteins coagulase and Efb in the Staphylococcus aureus–Candida interaction. Int. J. Med. Microbiol.303, 230–238.
53. Feller, L., Khammissa, R.A., Chandran, R., Altini, M., and Lemmer, J. 2014. Oral candidosis in relation to oral immunity. J. Oral Pathol. Med.43, 563–569.
54. Fernández-Arenas, E., Bleck, C.K.E., Nombela, C., Gil, C., Griffiths, G., and Diez-Orejas, R. 2009. Candida albicans actively modulates intracellular membrane trafficking in mouse macrophage phagosomes. Cell. Microbiol.11, 560–589.
55. Fidel, P.L. 2007. History and update on host defense against vaginal candidiasis. Am. J. Reprod. Immunol.57, 2–12.
56. Fling, M., Kopf, J., Tamarkin, A., Gorman, J., Smith, H., and Koltin, Y. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. MGG227, 318–329.
57. Foxman, B., Muraglia, R., Dietz, J., Sobel, J., and Wagner, J. 2013. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J. Low Genit. Tract. Dis.17, 340–345.
58. Frank, C.F. and Hostetter, M.K. 2007. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl. Res.149, 211–222.
59. Frohner, I.E., Bourgeois, C., Yatsyk, K., Majer, O., and Kuchler, K. 2009. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol. Microbiol.71, 240–252.
60. Gácser, A., Stehr, F., Kröger, C., Kredics, L., Schäfer, W., and Nosanchuk, J.D. 2007. Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun.75, 4710–4718.
61. Gantner, B.N., Simmons, R.M., and Underhill, D.M. 2005. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J.24, 1277–1286.
62. Garey, K.W., Rege, M., Pai, M.P., Mingo, D.E., Suda, K.J., Turpin, R.S., and Bearden, D.T. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin. Infect. Dis.77030, 25–31.
63. Gaur, N.K. and Klotz, S.A. 1997. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect. Immun.65, 5289–5294.
64. Geiger, J., Wessels, D., Lockhart, S.R., and Soll, D.R. 2004. Release of a potent polymorphonuclear leukocyte chemoattractant is regulated by white-opaque switching in Candida albicans. Infect. Immun.72, 667–677.
65. Ghannoum, M.A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev.13, 122–143.
66. Ghosh, S., Navarathna, D.H.M.L.P., Roberts, D.D., Cooper, J.T., Atkin, A.L., Petro, T.M., and Nickerson, K.W. 2009. Arginineinduced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. Infect. Immun.77, 1596–1605.
67. Gibson, J., Sood, A., and Hogan, D.A. 2009. Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol.75, 504–513.
68. Gladiator, A., Wangler, N., Trautwein-Weidner, K., and Leibund-Gut-Landmann, S. 2013. Cutting edge: IL-17–secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol.190, 521–525.
69. Götz, F., Bannerman, T., and Schleifer, K.H. 2006. The Genera Staphylococcus and Macrococcus. In Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.H., and Stackebrandt, E. (eds.), The Prokaryotes SE-1, pp. 5–75. Springer, USA.
70. Gow, N. 1997. Germ tube growth of Candida albicans. Curr. Top. Med. Mycol.8, 43–55.
71. Gow, N.A.R., Brown, A.J.P., and Odds, F.C. 2002. Fungal morphogenesis and host invasion. Curr. Opin. Microbiol.5, 366–371.
72. Gow, N.A. and Hube, B. 2012. Importance of the Candida albicans cell wall during commensalism and infection. Curr. Opin. Microbiol.15, 406–412.
73. Gow, N.A.R., Netea, M.G., Munro, C.A., Ferwerda, G., Bates, S., Mora-Montes, H.M., Walker, L., Jansen, T., Jacobs, L., Tsoni, V., et al. 2007. Immune recognition of Candida albicans β-glucan by dectin-1. J. Infect. Dis.196, 1565–1571.
74. Gow, N., Perera, T., Sherwood-Higham, J., Gooday, G., Gregory, D., and Marshall, D. 1994. Investigation of touch-sensitive responses by hyphae of the human pathogenic fungus Candida albicans. Scanning Microsc.8, 705–710.
75. Gow, N.A., van de Veerdonk, F.L., Brown, A.J., and Netea, M.G. 2012. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol.10, 112–122.
76. Green, D.R. 2011. Means to an End: Apoptosis and Other Cell Death Mechanisms. Cold Spring Harbor Laboratory Press.
77. Grimaudo, N.J., Nesbitt, W.E., and Clark, W.B. 1996. Coaggregation of Candida albicans oral Actinomyces species. Oral Microbiol. Immunol.11, 59–61.
78. Gropp, K., Schild, L., Schindler, S., Hube, B., Zipfel, P.F., and Skerka, C. 2009. The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol. Immunol.47, 465–475.
79. Guery, B.P., Arendrup, M.C., Auzinger, G., Azoulay, E., Borges Sá, M., Johnson, E.M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. 2009. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med.35, 55–62.
80. Hajjeh, R.A., Sofair, A.N., Harrison, L.H., Lyon, G.M., Arthingtonskaggs, B.A., Mirza, S.A., Phelan, M., Morgan, J., Lee-yang, W., Ciblak, M.A., et al. 2004. Incidence of bloodstream infections due to candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol.42, 1519–1527.
81. Harriott, M.M. and Noverr, M.C. 2009. Candida albicans and Staphylococcus aureus Form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob. Agents Chemother.53, 3914–3922.
82. Hebecker, B., Naglik, J.R., Hube, B., and Jacobsen, I.D. 2014. Pathogenicity mechanisms and host response during oral Candida albicans infections. Expert. Rev. Anti. Infect. Ther.12, 867–879.
83. Helmerhorst, E.J., Troxler, R.F., and Oppenheim, F.G. 2001. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA98, 14637–14642.
84. Hermann, C., Hermann, J., Munzel, U., and Rüchel, R. 1999. Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses42, 619–627.
85. Herre, J., Marshall, A.S.J., Caron, E., Edwards, A.D., Williams, D.L., Schweighoffer, E., Tybulewicz, V., Sousa, C.R.e, Gordon, S., and Brown, G.D. 2004. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood104, 4038–4045.
86. Hibino, K., Samaranayake, L.P., Hägg, U., Wong, R.W.K., and Lee, W. 2009. The role of salivary factors in persistent oral carriage of Candida in humans. Arch. Oral Biol.54, 678–683.
87. Hickey, D., Patel, M., Fahey, J., and Wira, C. 2011. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J. Reprod. Immunol.88, 185–194.
88. Hickey, D.K., Fahey, J.V., and Wira, C.R. 2013. Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, a-/β-defensins and TLRs. Innate Immun.19, 121–131.
89. Hiller, E., Zavrel, M., Hauser, N., Sohn, K., Burger-Kentischer, A., Lemuth, K., and Rupp, S. 2011. Adaptation, adhesion and invasion during interaction of Candida albicans with the host–focus on the function of cell wall proteins. Int. J. Med. Microbiol.301, 384–389.
90. Hogan, D.A. and Kolter, R. 2002. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science296, 2229–2232.
91. Hogan, D.A., Vik, Å., and Kolter, R. 2004. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol.54, 1212–1223.
92. Hollmig, S.T., Ariizumi, K., and Cruz, P.D. 2009. Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2. Glycobiology19, 568–575.
93. Holmes, A.R., McNab, R., and Jenkinson, H.F. 1996. Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions. Infect. Immun.64, 4680–4685.
94. Holmes, A.R., van der Wielen, P., Cannon, R.D., Ruske, D., and Dawes, P. 2006. Candida albicans binds to saliva proteins selectively adsorbed to silicone. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.102, 488–494.
95. Hornby, J.M., Jensen, E.C., Lisec, A.D., Tasto, J.J., Jahnke, B., Shoemaker, R., Dussault, P., and Nickerson, K.W. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol.67, 2982–2992.
96. Hoyer, L.L. 2001. The ALS gene family of Candida albicans. Trends Microbiol.9, 176–180.
97. Hube, B., Stehr, F., Bossenz, M., Mazur, A., Kretschmar, M., and Schäfer, W. 2000. Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch. Microbiol.174, 362–374.
98. Hughes, W. and Kim, H. 1973. Mycoflora in cystic fibrosis: Some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathol. Mycol. Appl.50, 261–269.
99. Ibata-Ombetta, S., Idziorek, T., Trinel, P.A., Poulain, D., and Jouault, T. 2003. Candida albicans phospholipomannan promotes survival of phagocytosed yeasts through modulation of bad phosphorylation and macrophage apoptosis. J. Biol. Chem.278, 13086–13093.
100. Jacobsen, I.D., Wilson, D., Wächtler, B., Brunke, S., Naglik, J.R., and Hube, B. 2012. Candida albicans dimorphism as a therapeutic target. Expert. Rev. Anti. Infect. Ther.10, 85–93.
101. Jenkinson, H. and Douglas, L. 2002. Candida interactions with bacterial biofilms, pp. 357–373. In Brogden, K. and Guthmiller, J. (eds.), Polymicrobial Infections and Disease. ASM Press. Washington, DC, USA.
102. Jenkinson, H.F., Lala, H.C., and Shepherd, M.G. 1990. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect. Immun.58, 1429–1436.
103. Joly, S., Ma, N., Sadler, J.J., Soll, D.R., Cassel, S.L., and Sutterwala, F.S. 2009. Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol.183, 3578–3581.
104. Kaksonen, M., Sun, Y., and Drubin, D.G. 2003. A pathway for association of receptors, adaptors, and actin during endocytic internalization. Cell115, 475–487.
105. Kaminishi, H., Miyaguchi, H., Tamaki, T., Suenaga, N., Hisamatsu, M., Mihashi, I., Matsumoto, H., Maeda, H., and Hagihara, Y. 1995. Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun.63, 984–988.
106. Kaneko, Y., Miyagawa, S., Takeda, O., Hakariya, M., Matsumoto, S., Ohno, H., and Miyazaki, Y. 2013. Real-time microscopic observation of candida biofilm development and effects due to micafungin and fluconazole. Antimicrob. Agents Chemother.57, 2226–2230.
107. Káposzta, R., Tree, P., Maródi, L., and Gordon, S. 1998. Characteristics of invasive candidiasis in gamma interferon- and interleukin- 4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun.66, 1708–1717.
108. Kebaara, B.W., Langford, M.L., Navarathna, D.H.M.L.P., Dumitru, R., Nickerson, K.W., and Atkin, A.L. 2008. Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction. Eukaryot. Cell7, 980–987.
109. Khader, S., Gaffen, S., and Kolls, J. 2009. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol.2, 403–411.
110. Klein, R.S., Harris, C.A., Small, C.B., Moll, B., Lesser, M., and Friedland, G.H. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med.311, 354–358.
111. Kojic, E.M. and Darouiche, R.O. 2004. Candida infections of medical devices. Clin. Microbiol. Rev.17, 255–267.
112. Koshlukova, S.E., Araujo, M.W.B., Baev, D., and Edgerton, M. 2000. Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect. Immun.68, 6848–6856.
113. Krishnakumari, V., Rangaraj, N., and Nagaraj, R. 2009. Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob. Agents Chemother.53, 256–260.
114. Kumagai, Y., Takeuchi, O., and Akira, S. 2015. Pathogen recognition by innate receptors. J. Infect. Chemother.14, 86–92.
115. Kumamoto, C.A. and Vinces, M.D. 2005. Alternative Candida albicans lifestyles: growth on surfaces. Annu. Rev. Microbiol.59, 113–133.
116. Kumar, R., Chadha, S., Saraswat, D., Bajwa, J.S., Li, R.A., Conti, H.R., and Edgerton, M. 2011. Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J. Biol. Chem.286, 43748–43758.
117. Kunze, D., Melzer, I., Bennett, D., Sanglard, D., MacCallum, D., Nörskau, J., Coleman, D.C., Odds, F.C., Schäfer, W., and Hube, B. 2005. Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans. Microbiology151, 3381–3394.
118. LaFleur, M.D., Kumamoto, C.A., and Lewis, K. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother.50, 3839–3846.
119. Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T., and Vandenabeele, P. 2006. Caspases in cell survival, proliferation and differentiation. Cell Death Differ.14, 44–55.
120. Leberer, E., Harcus, D., Broadbent, I., Clark, K., Dignard, D., Ziegelbauer, K., Schmidt, A., Gow, N., Brown, A., and Thomas, D. 1996. Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA93, 13217–13222.
121. Lehrer, R.I. and Ganz, T. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol.11, 23–27.
122. LeibundGut-Landmann, S., Grosz, O., Robinson, M.J., Osorio, F., Slack, E.C., Tsoni, S.V., Schweighoffer, E., Tybulewicz, V., Brown, G.D., Ruland, J., et al. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol.8, 630–638.
123. Leidich, S.D., Ibrahim, A.S., Fu, Y., Koul, A., Jessup, C., Vitullo, J., Fonzi, W., Mirbod, F., Nakashima, S., Nozawa, Y., et al. 1998. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem.273, 26078–26086.
124. Lermann, U. and Morschhäuser, J. 2008. Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology154, 3281–3295.
125. Lewis, K. 2010. Persister cells. Annu. Rev. Microbiol.64, 357–372.
126. Li, M., Chen, Q., Tang, R., Shen, Y., and Liu, W. 2011. The expression of beta-defensin-2,3 and LL-37 induced by Candida albicans phospholipomannan in human keratinocytes. J. Dermatol. Sci.61, 72–75.
127. Li, R., Kumar, R., Tati, S., Puri, S., and Edgerton, M. 2013. Candida albicans Flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity. Antimicrob. Agents Chemother.57, 1832–1839.
128. Li, F. and Palecek, S.P. 2003. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot. Cell2, 1266–1273.
129. Li, F. and Palecek, S.P. 2008. Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cell-substrate interactions. Microbiology154, 1193–1203.
130. Liu, H., Kohler, J., and Fink, G.R. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science266, 1723–1726.
131. Liu, L., Okada, S., Kong, X.F., Kreins, A.Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. 2011. Gainof-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med.208, 1635–1648.
132. Loza, L., Fu, Y., Ibrahim, A.S., Sheppard, D.C., Filler, S.G., and Edwards, J.E. 2004. Functional analysis of the Candida albicans ALS1 gene product. Yeast21, 473–482.
133. Luo, S., Blom, A.M., Rupp, S., Hipler, U.C., Hube, B., Skerka, C., and Zipfel, P.F. 2011. The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J. Biol. Chem.286, 8021–8029.
134. Luo, S., Hartmann, A., Dahse, H.M., Skerka, C., and Zipfel, P.F. 2010. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3. J. Immunol.185, 2164–2173.
135. Luo, S., Poltermann, S., Kunert, A., Rupp, S., and Zipfel, P.F. 2009. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol.47, 541–550.
136. Luo, S., Skerka, C., Kurzai, O., and Zipfel, P.F. 2013. Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans. Mol. Immunol.56, 161–169.
137. Marcil, A., Harcus, D., Thomas, D.Y., and Whiteway, M. 2002. Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of candida genotype, infection ratios, and gamma interferon treatment. Infect. Immun.70, 6319–6329.
138. Mardon, D., Balish, E., and Phillips, A. 1969. Control of dimorphism in a biochemical variant of Candida albicans. J. Bacteriol.100, 701–707.
139. Marger, M.D. and Saier Jr., M.H. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem. Sci.18, 13–20.
140. Maródi, L., Korchak, H.M., and Johnston, R.B. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol.146, 2783–2789.
141. Marr, K.A., Seidel, K., and White, T.C. 2000. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J. Infect. Dis.181, 309–316.
142. Martinon, F. and Tschopp, J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell117, 561–574.
143. Martinon, F., Mayor, A., and Tschopp, J. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol.27, 229–265.
144. Mayer, F.L., Wilson, D., and Hube, B. 2013. Candida albicans pathogenicity mechanisms. Virulence4, 119–128.
145. Mayer, F.L., Wilson, D., Jacobsen, I.D., Miramón, P., Groβe, K., and Hube, B. 2012. The novel Candida albicans transporter Dur31 is a multi-stage pathogenicity factor. PLoS Pathog.8, e1002592.
146. McCaig, L.F., McDonald, L.C., Mandal, S., and Jernigan, D.B. 2006. Staphylococcus aureus–associated skin and soft tissue infections in ambulatory care. Emerg. Infect. Dis. J.12, 1715.
147. McGreal, E.P., Rosas, M., Brown, G.D., Zamze, S., Wong, S.Y.C., Gordon, S., Martinez-Pomares, L., and Taylor, P.R. 2006. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiol.16, 422–430.
148. McKenzie, C.G.J., Koser, U., Lewis, L.E., Bain, J.M., Mora-Montes, H.M., Barker, R.N., Gow, N.A.R., and Erwig, L.P. 2010. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect. Immun.78, 1650–1658.
149. McMahon, H.T. and Boucrot, E. 2011. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol.12, 517–533.
150. Meiller, T.F., Hube, B., Schild, L., Shirtliff, M.E., Scheper, M.A., Winkler, R., Ton, A., and Jabra-Rizk, M.A. 2009. A novel immune evasion strategy of Candida albicans: Proteolytic cleavage of a salivary antimicrobial peptide. PLoS One4, e5039.
151. Merrifield, C.J., Feldman, M.E., Wan, L., and Almers, W. 2002. Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat. Cell Biol.4, 691–698.
152. Miceli, M.H., Díaz, J.A., and Lee, S.A. 2011. Emerging opportunistic yeast infections. Lancet Infect. Dis.11, 142–151.
153. Modrzewska, B. and Kurnatowski, P. 2015. Adherence of Candida sp. to host tissues and cells as one of its pathogenicity features. Ann. Parasitol.61, 3–9.
154. Moore, K.W., O’Garra, A., Malefyt, R.W., Vieira, P., and Mosmann, T.R. 1993. Interleukin-10. Annu. Rev. Immunol.11, 165–190.
155. Morales, D.K., Jacobs, N.J., Rajamani, S., Krishnamurthy, M., Cubillos-Ruiz, J.R., and Hogan, D.a 2010. Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills Candida albicans in biofilms. Mol. Microbiol.78, 1379–1392.
156. Moreno-Ruiz, E., Galán-Díez, M., Zhu, W., Fernández-Ruiz, E., D’Enfert, C., Filler, S.G., Cossart, P., and Veiga, E. 2009. Candida albicans internalization by host cells is mediated by a clathrindependent mechanism. Cell. Microbiol.11, 1179–1189.
157. Moyes, D.L., Murciano, C., Runglall, M., Islam, A., Thavaraj, S., and Naglik, J.R. 2011. Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PLoS One6, e26580.
158. Moyes, D.L., Murciano, C., Runglall, M., Kohli, A., Islam, A., and Naglik, J.R. 2012. Activation of MAPK/c-Fos induced responses in oral epithelial cells is specific to Candida albicans and Candida dubliniensis hyphae. Med. Microbiol. Immunol.201, 93–101.
159. Moyes, D.L., Richardson, J.P., and Naglik, J.R. 2015. Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface. Virulence6, 338–346.
160. Moyes, D.L., Runglall, M., Murciano, C., Shen, C., Nayar, D., Thavaraj, S., Kohli, A., Islam, A., Mora-Montes, H., Challacombe, S.J., et al. 2010. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe8, 225–235.
161. Moyes, D.L., Shen, C., Murciano, C., Runglall, M., Richardson, J.P., Arno, M., Aldecoa-Otalora, E., and Naglik, J.R. 2014. Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling. J. Infect. Dis.209, 1816–1826.
162. Naglik, J.R. and Moyes, D. 2011. Epithelial cell innate response to Candida albicans. Adv. Dent. Res.23, 50–55.
163. Naglik, J.R., Moyes, D., Makwana, J., Kanzaria, P., Tsichlaki, E., Weindl, G., Tappuni, A.R., Rodgers, C.a., Woodman, A.J., Challacombe, S.J., et al. 2008. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology154, 3266–3280.
164. Naglik, J.R., Moyes, D.L., Wächtler, B., and Hube, B. 2011. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect.13, 963–976.
165. Nair, N., Biswas, R., Götz, F., and Biswas, L. 2014. Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections. Infect. Immun.82, 2162–2169.
166. Netea, M.G., Brown, G.D., Kullberg, B.J., and Gow, N.A.R. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol.6, 67–78.
167. Netea, M.G. and Maródi, L. 2010. Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol.31, 346–353.
168. Netea, M.G., Sutmuller, R., Hermann, C., Van der Graaf, C.A.A., Van der Meer, J.W.M., van Krieken, J.H., Hartung, T., Adema, G., and Kullberg, B.J. 2004. Toll-Like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol.172, 3712–3718.
169. Nett, J.E., Crawford, K., Marchillo, K., and Andes, D.R. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother.54, 3505–3508.
170. Nett, J.E., Lepak, A.J., Marchillo, K., and Andes, D.R. 2009. Time course global gene expression analysis of an in vivo Candida biofilm. J. Infect. Dis.200, 307–313.
171. Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., and Andes, D. 2007. Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother.51, 510–520.
172. Niewerth, M. and Korting, H.C. 2001. Phospholipases of Candida albicans. Mycoses44, 361–367.
173. Nobile, C.J., Fox, E.P., Nett, J.E., Sorrells, T.R., Mitrovich, Q.M., Hernday, A.D., Tuch, B.B., Andes, D.R., and Johnson, A.D. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell148, 126–138.
174. Nobile, C.J., Schneider, H.A., Nett, J.E., Sheppard, D.C., Filler, S.G., Andes, D.R., and Mitchell, A.P. 2008. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol.18, 1017–1024.
175. Noverr, M.C. and Huffnagle, G.B. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun.72, 6206–6210.
176. Odds, F.C. 1988. Candida and Candidosis. Baillière Tindall.
177. Odds, F.C. 2008. Secreted proteinases and Candida albicans virulence. Microbiology154, 3245–3246.
178. Oever, J.T. and Netea, M.G. 2014. The bacteriome-mycobiome interaction and antifungal host defense. Eur. J. Immunol.44, 3182–3191.
179. Onishi, R.M. and Gaffen, S.L. 2010. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology129, 311–321.
180. Otte, J.M., Zdebik, A.E., Brand, S., Chromik, A.M., Strauss, S., Schmitz, F., Steinstraesser, L., and Schmidt, W.E. 2009. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul. Pept.156, 104–117.
181. Park, H., Myers, C.L., Sheppard, D.C., Phan, Q.T., Sanchez, A.A., E. Edwards, J., and Filler, S.G. 2005. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell. Microbiol.7, 499–510.
182. Peleg, A.Y., Tampakakis, E., Fuchs, B.B., Eliopoulos, G.M., Moellering, R.C., and Mylonakis, E. 2008. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA105, 14585–14590.
183. Perlroth, J., Choi, B., and Spellberg, B. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol.45, 321–346.
184. Peschel, A. and Sahl, H.G. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol.4, 529–536.
185. Peters, B.M., Ovchinnikova, E.S., Krom, B.P., Schlecht, L.M., Zhou, H., Hoyer, L.L., Busscher, H.J., van der Mei, H.C., Jabra-Rizk, M.A., and Shirtliff, M.E. 2012. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology158, 2975–2986.
186. Pfaller, M.A. and Diekema, D.J. 2010. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol.36, 1–53.
187. Phan, Q.T., Belanger, P.H., and Filler, S.G. 2000. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun.68, 3485–3490.
188. Phan, Q.T., Fratti, R.A., Prasadarao, N.V., Edwards, J.E., and Filler, S.G. 2005. N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J. Biol. Chem.280, 10455–10461.
189. Phan, Q.T., Myers, C.L., Fu, Y., Sheppard, D.C., Yeaman, M.R., Welch, W.H., Ibrahim, A.S., Edwards, J.E., and Filler, S.G. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol.5, e64.
190. Powell, B.L., Frey, C.L., and Drutz, D.J. 1984. Identification of a 17p-estradiol binding protein in Candida albicans and Candida (Torulopsis) glabrata. Exp. Mycol.8, 304–313.
191. Prasad, R., De Wergifosse, P., Goffeau, A., and Balzi, E. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet.27, 320–329.
192. Puel, A., Cypowyj, S., Bustamante, J., Wright, J.F., Liu, L., Lim, H.K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science332, 65–68.
193. Puel, A., Döffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachée-Chardin, M., Toulon, A., Bustamante, J., et al. 2010. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med.207, 291–297.
194. Puri, S., Kumar, R., Chadha, S., Tati, S., Conti, H.R., Hube, B., Cullen, P.J., and Edgerton, M. 2012. Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis. PLoS One7, e46020.
195. Ramage, G., Bachmann, S., Patterson, T.F., Wickes, B.L., and López-Ribot, J.L. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother.49, 973–980.
196. Ramage, G., Martínez, J.P., and López-Ribot, J.L. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res.6, 979–986.
197. Ramage, G., Mowat, E., Jones, B., Williams, C., and Lopez-Ribot, J. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol.35, 340–355.
198. Rauceo, J.M., De Armond, R., Otoo, H., Kahn, P.C., Klotz, S.A., Gaur, N.K., and Lipke, P.N. 2006. Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p. Eukaryot. Cell5, 1664–1673.
199. Ray, T.L. and Payne, C.D. 1988. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect. Immun.56, 1942–1949.
200. Re, F. and Strominger, J.L. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem.276, 37692–37699.
201. Rollenhagen, C., Wöllert, T., Langford, G.M., and Sundstrom, P. 2009. Stimulation of cell motility and expression of late markers of differentiation in human oral keratinocytes by Candida albicans. Cell. Microbiol.11, 946–966.
202. Rosentul, D.C., Plantinga, T.S., Oosting, M., Scott, W.K., Velez Edwards, D.R., Smith, P.B., Alexander, B.D., Yang, J.C., Laird, G.M., Joosten, L.A.B., et al. 2011. Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J. Infect. Dis.204, 1138–1145.
203. Rotstein, D., Parodo, J., Taneja, R., and Marshall, J.C. 2000. Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock14, 278–283.
204. Saijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., Kusaka, T., Kubo, S., Chung, S., et al. 2010. Dectin-2 recognition of a-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity32, 681–691.
205. Sallusto, F. and Lanzavecchia, A. 2002. The instructive role of dendritic cells on T-cell responses. Arthritis Res. 4 Suppl 3, 127–1
206. Sandini, S., La Valle, R., De Bernardis, F., Macrì, C., and Cassone, A. 2007. The 65 kDa mannoprotein gene of Candida albicans encodes a putative β-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell. Microbiol.9, 1223–1238.
207. Sanglard, D. 2002. Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol.5, 379–385.
208. Sanglard, D., Ischer, F., Monod, M., and Bille, J. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology143, 405–416.
209. Sasse, C., Hasenberg, M., Weyler, M., Gunzer, M., and Morschhäuser, J. 2013. White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion. Eukaryot. Cell12, 50–58.
210. Saville, S.P., Lazzell, A.L., Monteagudo, C., and Lopez-ribot, J.L. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell2, 1053–1060.
211. Schaller, M., Mailhammer, R., Grassl, G., Sander, C.A., Hube, B., and Korting, H.C. 2002. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J. Invest. Dermatol.118, 652–657.
212. Schaller, M., Borelli, C., Korting, H.C., and Hube, B. 2005. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses48, 365–377.
213. Schauber, J., Svanholm, C., Termén, S., Iffland, K., Menzel, T., Scheppach, W., Melcher, R., Agerberth, B., Lührs, H., and Gudmundsson, G.H. 2003. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut52, 735–741.
214. Scherwitz, C. 1982. Ultrastructure of human cutaneous candidosis. J. Investig. Dermatol.78, 200–205.
215. Sealy, P.I., Garner, B., Swiatlo, E., Chapman, S.W., and Cleary, J.D. 2008. The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection. Med. Mycol.46, 531–539.
216. Seider, K., Heyken, A., Lüttich, A., Miramón, P., and Hube, B. 2010. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr. Opin. Microbiol.13, 392–400.
217. Sheppard, D.C., Yeaman, M.R., Welch, W.H., Phan, Q.T., Fu, Y., Ibrahim, A.S., Filler, S.G., Zhang, M., Waring, A.J., and Edwards, J.E. 2004. Functional and structural diversity in the Als protein family of Candida albicans. J. Biol. Chem.279, 30480–30489.
218. Shirtliff, M.E., Peters, B.M., and Jabra-Rizk, M.A. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett.299, 1–8.
219. Simonetti, N., Strippoli, V., and Cassone, A. 1974. Yeast-mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans. Nature250, 344–346.
220. Smeekens, S.P., Plantinga, T.S., van de Veerdonk, F.L., Heinhuis, B., Hoischen, A., Joosten, L.A., Arkwright, P.D., Gennery, A., Kullberg, B.J., Veltman, J.A., et al. 2011. STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One6, e29248.
221. Sobel, J.D. 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis.14, S148–153.
222. Sobel, J.D. 2015. Recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. DOI: http://dx.doi.org/10.1016/j.ajog.2015.06.067
223. Spellberg, B. 2008. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog.4, e38.
224. Staab, J.F., Bahn, Y.S., Tai, C.H., Cook, P.F., and Sundstrom, P. 2004. Expression of transglutaminase substrate activity on Candida albicans germ tubes through a coiled, disulfide-bonded N-terminal domain of Hwp1 requires C-terminal glycosylphosphatidylinositol modification. J. Biol. Chem.279, 40737–40747.
225. Staab, J.F., Bradway, S.D., Fidel, P.L., and Sundstrom, P. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Sciences283, 1535–1538.
226. Stoldt, V.R., Sonneborn, A., Leuker, C.E., and Ernst, J.F. 1996. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J.16, 1982–1991.
227. Strober, W. 2004. Epithelial cells pay a Toll for protection. Nat. Med.10, 898–900.
228. Sudbery, P.E. 2011. Growth of Candida albicans hyphae. Nat. Rev. Microbiol.9, 737–748.
229. Sullivan, J.M.O., Jenkinson, H.F., and Cannon, R.D. 2000. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology146, 41–48.
230. Sun, J.N., Li, W., Jang, W.S., Nayyar, N., Sutton, M.D., and Edgerton, M. 2008. Uptake of the antifungal cationic peptide Histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain. Mol. Microbiol.70, 1246–1260.
231. Sun, J.N., Solis, N.V., Phan, Q.T., Bajwa, J.S., Kashleva, H., Thompson, A., Liu, Y., Dongari-Bagtzoglou, A., Edgerton, M., and Filler, S.G. 2010. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog.6, e1001181.
232. Sundstrom, P., Balish, E., and Allen, C.M. 2002. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J. Infect. Dis.185, 521–530.
233. Swidergall, M. and Ernst, J.F. 2014. Interplay between Candida albicans and the antimicrobial peptide armory. Eukaryot. Cell13, 950–957.
234. Swidergall, M., Ernst, A.M., and Ernst, J.F. 2013. Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides. Antimicrob. Agents Chemother.57, 3917–3922.
235. Szafranski-Schneider, E., Swidergall, M., Cottier, F., Tielker, D., Román, E., Pla, J., and Ernst, J.F. 2012. Msb2 shedding protects Candida albicans against antimicrobial peptides. PLoS Pathog.8, e1002501.
236. Taff, H.T., Nett, J.E., Zarnowski, R., Ross, K.M., Sanchez, H., Cain, M.T., Hamaker, J., Mitchell, A.P., and Andes, D.R. 2012. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog.8, e1002848.
237. Takesue, Y., Kakehashi, M., Ohge, H., Imamura, Y., Murakami, Y., Sasaki, M., Morifuji, M., Yokoyama, Y., Kouyama, M., Yokoyama, T., et al. 2004. Combined assessment of beta-D-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J. Surg.28, 625–630.
238. Takezaki, S., Yamada, M., Kato, M., Park, M.J., Maruyama, K., Yamazaki, Y., Chida, N., Ohara, O., Kobayashi, I., and Ariga, T. 2012. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J. Immunol.189, 1521–1526.
239. Taschdjian, C., Burchall, J., and Kozinn, P. 1960. Rapid identification of Candida albicans by filamentation on serum and serum substitutes. AMA. J. Dis. Child.99, 212–215.
240. Tsai, P.W., Yang, C.Y., Chang, H.T., and Lan, C.Y. 2011. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS One6, e17755.
241. Underhill, D.M. and Iliev, I.D. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol.14, 405–416.
242. Uppuluri, P., Chaturvedi, A.K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A.K., Köhler, J.R., Kadosh, D., and Lopez-Ribot, J.L. 2010. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog.6, e1000828.
243. Urban, C.F., Reichard, U., Brinkmann, V., and Zychlinsky, A. 2006. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell. Microbiol.8, 668–676.
244. Urban, C.F., Ermert, D., Schmid, M., Abu-Abed, U., Goosmann, C., Nacken, W., Brinkmann, V., Jungblut, P.R., and Zychlinsky, A. 2009. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog.5, e1000639.
245. Van’t Wout, J.W., Linde, I., Leijh, P.C.J., and van Furth, R. 1988. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur. J. Clin. Microbiol. Infect. Dis.7, 736–741.
246. Van de Veerdonk, F.L. and Joosten, L.A.B. 2015. The interplay between inflammasome activation and antifungal host defense. Immunol. Rev.265, 172–180.
247. Van de Veerdonk, F.L., Kullberg, B.J., and Netea, M.G. 2010. Pathogenesis of invasive candidiasis. Curr. Opin. Crit. Care16, 453–459.
248. Van de Veerdonk, F.L., Plantinga, T., Hoischen, A., Smeekens, S., Joosten, L., Gilissen, C., Arts, P., Rosentul, D., Carmichael, A., Smits-van der Graaf, C., et al. 2011. STAT1 Mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl. J. Med.365, 54–61.
249. Van der Meer, J.W., van de Veerdonk, F.L., Joosten, L.A., Kullberg, B.J., and Netea, M.G. 2010. Severe Candida spp. infections: new insights into natural immunity. Int. J. Antimicrob. Agents 36 Suppl 2, S58–62.
250. Verma, S. and Hefferman, M. 2008. Superficial fungal infection: dermatophytosis, onychomytosis, tinea nigra, piedra, pp. 1807–1821. In Wolff, K., Goldsmith, L., Katz, S., Gilchrest, B., Paller, A.S., and Leffell, D.J. (eds.). Fitzpatrick’s Dermatology in General Medicine. McGraw-Hill, New York, USA.
251. Villar, C., Chukwuedum Aniemeke, J., Zhao, X.R., and Huynh-Ba, G. 2012. Induction of apoptosis in oral epithelial cells by Candida albicans. Mol. Oral Microbiol.27, 436–448.
252. Villar, C.C., Kashleva, H., Nobile, C.J., Mitchell, A.P., and Dongari-Bagtzoglou, A. 2007. Mucosal tissue invasion by Candida albicans is associated with e-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun.75, 2126–2135.
253. Villar, C.C. and Zhao, X.R. 2010. Candida albicans induces early apoptosis followed by secondary necrosis in oral epithelial cells. Mol. Oral Microbiol.25, 215–225.
254. Villena, J., Salva, S., Agüero, G., and Alvarez, S. 2011. Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol. Immunol.55, 434–445.
255. Vylkova, S., Carman, A.J., Danhof, H.A., Collette, J.R., Zhou, H., and Lorenz, M.C. 2011. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio2, 1–12.
256. Wächtler, B., Citiulo, F., Jablonowski, N., Förster, S., Dalle, F., Schaller, M., Wilson, D., and Hube, B. 2012. Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLoS One7, e36952.
257. Wächtler, B., Wilson, D., Haedicke, K., Dalle, F., and Hube, B. 2011. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One6, e17046
258. Wagener, J., Weindl, G., de Groot, P.W.J., de Boer, A.D., Kaesler, S., Thavaraj, S., Bader, O., Mailänder-Sanchez, D., Borelli, C., Weig, M., et al. 2012. Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells. PLoS One7, e50518.
259. Weindl, G., Naglik, J.R., Kaesler, S., Biedermann, T., Hube, B., Korting, H.C., and Schaller, M. 2007. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J. Clin. Invest.117, 3664–3672.
260. Weindl, G., Wagener, J., and Schaller, M. 2010. Epithelial cells and innate antifungal defense. J. Dent. Res.89, 666–675.
261. Weindl, G., Wagener, J., and Schaller, M. 2011. Interaction of the mucosal barrier with accessory immune cells during fungal infection. Int. J. Med. Microbiol.301, 431–435.
262. Wheeler, R.T., Kombe, D., Agarwala, S.D., and Fink, G.R. 2008. Dynamic, morphotype-specific Candida albicans β-Glucan exposure during infection and drug treatment. PLoS Pathog.4, e1000227.
263. White, T.C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother.41, 1482–1487.
264. White, S., Larsen, B., and Virginia, H.W. 1997. Candida albicans morphogenesis is influenced by estrogen. Cell Mol. Life Sci.53, 744–749.
265. Williams, P. and Cámara, M. 2009. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr. Opin. Microbiol.12, 182–191.
266. Williams, D.W., Jordan, R.P., Wei, X.Q., Alves, C.T., Wise, M.P., Wilson, M.J., and Lewis, M.A. 2013. Interactions of Candida albicans with host epithelial surfaces. J. Oral Microbiol.5. doi: 10.3402/jom.v5i0.22434.
267. Willment, J.A. and Brown, G.D. 2008. C-type lectin receptors in antifungal immunity. Trends Microbiol.16, 27–32.
268. Xie, Z., Thompson, A., Sobue, T., Kashleva, H., Xu, H., Vasilakos, J., and Dongari-Bagtzoglou, A. 2012. Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing. J. Infect. Dis.206, 1936–1945.
269. Yan, L., Yang, C., and Tang, J. 2013. Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol. Res.168, 389–395.
270. Yang, W., Yan, L., Wu, C., Zhao, X., and Tang, J. 2014. Fungal invasion of epithelial cells. Microbiol. Res.169, 803–810.
271. Yano, J., Lilly, E., Barousse, M., and Fidel, P.L. 2010. Epithelial cellderived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect. Immun.78, 5126–5137.
272. Yarar, D., Waterman-Storer, C.M., and Schmid, S.L. 2005. A dynamic actin cytoskeleton functions at multiple stages of clathrinmediated endocytosis. Mol. Biol. Cell16, 964–975.
273. Ye, P., Rodriguez, F.H., Kanaly, S., Stocking, K.L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med.194, 519–527.
274. Zakikhany, K., Naglik, J.R., Schmidt-Westhausen, A., Holland, G., Schaller, M., and Hube, B. 2007. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol.9, 2938–2954.
275. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. 2013. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity39, 372–385.
276. Zhang, M.X., Lupan, D.M., and Kozel, T.R. 1997. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans. Infect. Immun.65, 3822–3827.
277. Zhang, M.X. and Kozel, T.R. 1998. Mannan-specific immunoglobuling antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway. Infect. Immun.66, 4845–4850.
278. Zhao, X., Oh, S.H., Cheng, G., Green, C., Nuessen, J., Yeater, K., Leng, R., Brown, A., and Hoyer, L. 2004. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology150, 2415–2428.
279. Zhao, X., Oh, S.H., Yeater, K.M., and Hoyer, L.L. 2005. Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology151, 1619–1630.
280. Zhu, W. and Filler, S.G. 2010. Interactions of Candida albicans with epithelial cells. Cell. Microbiol.12, 273–282.
281. Zhu, W., Phan, Q.T., Boontheung, P., Solis, N.V., Loo, J.A., and Filler, S.G. 2012. EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc. Natl. Acad. Sci. USA109, 14194–14199.
282. Zipfel, P.F., Skerka, C., Kupka, D., and Luo, S. 2011. Immune escape of the human facultative pathogenic yeast Candida albicans: the many faces of the Candida Pra1 protein. Int. J. Med. Microbiol.301, 423–430.